{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T22:16:54Z","timestamp":1792707414520,"version":"4.5.0"},"reference-count":65,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2008,12,23]],"date-time":"2008-12-23T00:00:00Z","timestamp":1229990400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur J Clin Pharmacol"],"published-print":{"date-parts":[[2009,4]]},"DOI":"10.1007\/s00228-008-0599-y","type":"journal-article","created":{"date-parts":[[2008,12,22]],"date-time":"2008-12-22T15:19:20Z","timestamp":1229959160000},"page":"419-427","source":"Crossref","is-referenced-by-count":84,"title":["Clinical pharmacokinetics of aminoglycosides in the neonate: a review"],"prefix":"10.1007","volume":"65","author":[{"given":"Gian Maria","family":"Pacifici","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2008,12,23]]},"reference":[{"key":"599_CR1","unstructured":"Hickey SM, McCracken G Jr (1997) Postnatal bacterial infections. In: Fanaroff AA, Martin RJ (eds) Neonatal-perinatal medicine: diseases of the fetus and infant, 6th ed. Mosby, St Louis, pp 717\u2013731"},{"key":"599_CR2","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1126\/science.135.3508.1067","volume":"135","author":"PH Plotz","year":"1962","unstructured":"Plotz PH, Davis BD (1962) Synergy between streptomycin and penicillin: a proposed mechanism. Science 135:1067\u20131068","journal-title":"Science"},{"key":"599_CR3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000457657","volume":"11","author":"M Bonati","year":"1988","unstructured":"Bonati M (1988) Early neonatal drug utilisation in preterm newborns in neonatal intensive care units: Italian Collaborative Group on Preterm Delivery. Dev Pharm Ther 11:1\u20137","journal-title":"Dev Pharm Ther"},{"key":"599_CR4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0095-5108(18)30195-7","volume":"24","author":"MS Edwards","year":"1997","unstructured":"Edwards MS (1997) Antibacterial therapy in pregnancy and neonates. Clin Perinatol 24:59\u201370","journal-title":"Clin Perinatol"},{"key":"599_CR5","unstructured":"Chambers HF (2006) The aminoglycosides. In: Brunton LL, Lazo JS, Parker KL (eds.) Goodman & Gilman\u2019s the pharmacologic basis of therapeutics, 11th ed. McGraw Hill, New York, pp 1155\u20131171"},{"key":"599_CR6","unstructured":"Thummel KE, Shen DD, Isoherranen N, Smit HE (2006) Design and optimization of dosage regimens: pharmacokinetic data. In: Brunton LL, Lazo JS, Parker KL (eds.) Goodman & Gilman\u2019s the pharmacologic basis of therapeutics, 11th ed. McGraw Hill, New York, pp 1787\u20131888"},{"key":"599_CR7","unstructured":"Young TE, Mangum B (2007) The antibiotics. Neofax: a manual of drugs used in neonatal care, 20th ed. Thomson Healthcare, Montvale, NJ, USA, pp 2-77"},{"key":"599_CR8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S0030-6665(20)30762-3","volume":"5","author":"GJ Matz","year":"1993","unstructured":"Matz GJ (1993) Aminoglycoside cochlear ototoxicity. Otoryngol Clin North Am 5:705\u2013712","journal-title":"Otoryngol Clin North Am"},{"key":"599_CR9","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s004670050214","volume":"10","author":"S Andronikou","year":"1996","unstructured":"Andronikou S, Giapros VI, Cholevas VI, Popadopoulou ZL (1996) Effect of aminoglycosides therapy on renal function in fullterm infants. Pediatr Nephrol 10:766\u2013768","journal-title":"Pediatr Nephrol"},{"key":"599_CR10","first-page":"27","volume":"17","author":"SK Swan","year":"1997","unstructured":"Swan SK (1997) Aminoglycoside nephrotoxicity. Semin Nephrol 17:27\u201333","journal-title":"Semin Nephrol"},{"key":"599_CR11","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1007\/BF02185842","volume":"8","author":"IM Kovarik","year":"1989","unstructured":"Kovarik JM, Hoepelman IM, Verhoef J (1989) Once-daily aminoglycoside administration: new strategies for old drug. Eur J Clin Microb Infect Dis 8:764\u2013769","journal-title":"Eur J Clin Microb Infect Dis"},{"key":"599_CR12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/BF00542216","volume":"24","author":"KW Hindmarsh","year":"1983","unstructured":"Hindmarsh KW, Nation RL, Williams GL, John E, French JN (1983) Pharmacokinetics of gentamicin in very low birth weight preterm infants. Eur J Clin Pharmacol 24:649\u2013953","journal-title":"Eur J Clin Pharmacol"},{"key":"599_CR13","first-page":"1075","volume":"34","author":"L Krishnan","year":"1977","unstructured":"Krishnan L, George SA (1977) Gentamicin therapy in preterms: a comparison of two dosage regimens. Indian Pediatr 34:1075\u20131080","journal-title":"Indian Pediatr"},{"key":"599_CR14","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00006454-199812000-00017","volume":"17","author":"C Alba Romero de","year":"1998","unstructured":"de Alba Romero C, Gomez Castillo E, Manzanares Secades C, Rodriguez Lopez J, Arreaza Lopez J, Saenz Valiente P (1998) Once-daily gentamicin dosing in neonates. Pediatr Infect Dis J 17:1169\u20131171","journal-title":"Pediatr Infect Dis J"},{"key":"599_CR15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/sj.jp.7210704","volume":"22","author":"G Agarwal","year":"2002","unstructured":"Agarwal G, Rastogi A, Pyati S, Wilks A, Pildes RS (2002) Comparison of once-daily versus twice-daily gentamicin dosing regimens in infant \u22652500\u00a0g. J Perinatol 22:268\u2013274","journal-title":"J Perinatol"},{"key":"599_CR16","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1542\/peds.103.3.594","volume":"103","author":"PJ Thureen","year":"1999","unstructured":"Thureen PJ, Reiter PD, Gresores A, Stolpman NM, Kawato K, Hall DM (1999) Once- versus twice-daily gentamicin dosing in neonates \u226534\u00a0weeks\u2019s gestation: cost-effectiveness analyses. Pediatrics 103:594\u2013598","journal-title":"Pediatrics"},{"key":"599_CR17","first-page":"CD005091","volume":"25","author":"EM Rao","year":"2006","unstructured":"Rao EM, Ahmed M, Hagan R (2006) One dose per day compared to multiple doses per day of gentamicin for treatment of suspected or proven sepsis in neonates. Cochrane Database Syst Rev 25:CD005091","journal-title":"Cochrane Database Syst Rev"},{"key":"599_CR18","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1097\/00006454-200112000-00016","volume":"20","author":"D Miron","year":"2001","unstructured":"Miron D (2001) Once daily dosing of gentamicin in infants and children. Pediatr Infect Dis J 20:1169\u20131173","journal-title":"Pediatr Infect Dis J"},{"key":"599_CR19","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/00006454-200203000-00014","volume":"21","author":"A Rastogi","year":"2002","unstructured":"Rastogi A, Agarwal G, Pyati S, Pilles R (2002) Comparison of two gentamicin dosing schedules in very low birth weight infants. Pediatr Infect Dis J 21:234\u2013240","journal-title":"Pediatr Infect Dis J"},{"key":"599_CR20","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1055\/s-2002-36836","volume":"19","author":"ML Avent","year":"2002","unstructured":"Avent ML, Kinney JS, Istre GR, Whitfield JM (2002) Gentamicin and tobramycin in neonates: comparison of a new extended dosing interval regimen with a traditional multiple daily dosing regimen. Am J Perinatol 19:413\u2013419","journal-title":"Am J Perinatol"},{"key":"599_CR21","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1093\/jac\/dkh261","volume":"54","author":"JM Lanao","year":"2004","unstructured":"Lanao JM, Calvo MV, Mesa JA, Martin-Suarez A, Carbajosa MT, Miguelez F, Dominguex-Gill A (2004) Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates. J Antimicrob Chemother 54:193\u2013198","journal-title":"J Antimicrob Chemother"},{"key":"599_CR22","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1055\/s-2004-820515","volume":"21","author":"MCK Mercado","year":"2004","unstructured":"Mercado MCK, Brodsky NL, McGuire MK, Hurt H (2004) Extended interval dosing of gentamicin in preterm infants. Am J Perinatol 21:73\u201377","journal-title":"Am J Perinatol"},{"key":"599_CR23","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1097\/INF.0b013e318059c25b","volume":"26","author":"GL Darmastads","year":"2007","unstructured":"Darmastads GL, Hossain MM, Jana AK, Saha SK, Choi Y, Sridhar S, Thomas N, Miller-bell M, Edwards D, Aranda J, Willis J, Coffey P (2007) Determination of extended-interval gentamicin dosing for neonatal patients in developing countries. Pediatr Infect Dis J 26:501\u2013507","journal-title":"Pediatr Infect Dis J"},{"key":"599_CR24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1086\/313692","volume":"30","author":"SK Chuck","year":"2000","unstructured":"Chuck SK, Raber SR, Rodvold KA, Areff D (2000) National survey of extended-interval aminoglycoside dosing. Clin Infect Dis 30:433\u2013439","journal-title":"Clin Infect Dis"},{"key":"599_CR25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0924-8579(02)00030-4","volume":"19","author":"D Maglio","year":"2002","unstructured":"Maglio D, Nightingale CH, Nicolau DP (2002) Extended interval aminoglycoside dosing: from concept to clinic. Int J Antimicrob Agents 19:341\u2013348","journal-title":"Int J Antimicrob Agents"},{"key":"599_CR26","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000244137","volume":"67","author":"WM Semckuk","year":"1995","unstructured":"Semckuk WM, Shevchuk YM, Sankaran K, Wallace SM (1995) Prospective, randomized, controlled evaluation of a gentamicin loading dose in neonates. Biol Neonate 67:13\u201320","journal-title":"Biol Neonate"},{"key":"599_CR27","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/00007691-198901000-00004","volume":"11","author":"KL Wattenberg","year":"1989","unstructured":"Wattenberg KL, Kelly HW, Angelus P, Backstrom C (1989) The need for a loading dose of gentamicin in neonates. Ther Drug Monit 11:16\u201320","journal-title":"Ther Drug Monit"},{"key":"599_CR28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1097\/00007691-199610000-00005","volume":"18","author":"BT Iseman","year":"1996","unstructured":"Iseman BT, Kotagal UR, Mashni SM, Luckhaupt EJ, Johnson CJ (1996) Optimal gentamicin therapy in preterm neonates includes loading doses and early monitoring. Ther Drug Monit 18:549\u2013555","journal-title":"Ther Drug Monit"},{"key":"599_CR29","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-2007-999494","volume":"7","author":"P Gal","year":"1990","unstructured":"Gal P, Ransom L, Weaver RL (1990) Gentamicin in neonates: the need for loading doses. Am J Perinatol 7:254\u2013257","journal-title":"Am J Perinatol"},{"key":"599_CR30","doi-asserted-by":"crossref","unstructured":"Gosden PE, Bedford KA, Dixon JJ, Speidel BD, Leaf AA Macgowan (2001) Pharmacokinetics of once-a-day netilmicin [4.5\u00a0mg\/kg] in neonates. J Chemother 13:270\u2013276","DOI":"10.1179\/joc.2001.13.3.270"},{"key":"599_CR31","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000079423","volume":"86","author":"JR Brooks","year":"2004","unstructured":"Brooks JR, Marlow N, Reeves BC, Millar MR (2004) Use of once-daily netilmicin to treat infants with suspected sepsis in a neonatal intensive care unit. Biol Neonate 86:170\u2013175","journal-title":"Biol Neonate"},{"key":"599_CR32","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/jac\/38.3.499","volume":"38","author":"JJ Ettlinger","year":"1996","unstructured":"Ettlinger JJ, Bedford KA, Lovering AM, Reeves DS, Speidel BD, MacGowan AP (1996) Pharmacokinetics of once-a-day netilmicin [6\u00a0mg\/kg] in neonates. J Antimicrob Chemother 38:499\u2013505","journal-title":"J Antimicrob Chemother"},{"key":"599_CR33","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1080\/00365540410020613","volume":"36","author":"C Klingenberg","year":"2004","unstructured":"Klingenberg C, Smabrekke L, lier T, Flaegstad T (2004) Validation of a simplified netilmicin dosage regimen in infants. Scand J Infect Dis 36:474\u2013479","journal-title":"Scand J Infect Dis"},{"key":"599_CR34","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF00635907","volume":"29","author":"RJ Kuhn","year":"1986","unstructured":"Kuhn RJ, Nahata MC, Powell DA, Bickers RG (1986) Pharmacokinetics of netilmicin in premature infants. Eur J Clin Pharmacol 29:635\u2013637","journal-title":"Eur J Clin Pharmacol"},{"key":"599_CR35","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S0022-3476(85)80099-8","volume":"106","author":"A Granati","year":"1985","unstructured":"Granati A, Assael BM, Chung M, Montini C, Parini R, Pallazzon P, Gagliardi L, Radwanski E, Rubaltelli FF (1985) Clinical pharmacology of netilmicin in preterm and term newborn infants. J Pediatr 106:664\u2013669","journal-title":"J Pediatr"},{"key":"599_CR36","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1128\/AAC.15.2.246","volume":"15","author":"JD Siegel","year":"1979","unstructured":"Siegel JD, McCracken GH, Thomas ML, Threlkeld N (1979) Pharmacokinetic properties of netilmicin in newborn infants. Antimicrob Agents Chemother 15:246\u2013253","journal-title":"Antimicrob Agents Chemother"},{"key":"599_CR37","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1159\/000067014","volume":"83","author":"B Berger","year":"2003","unstructured":"Berger B, Kretzer V, Gludovatz P, Rohrmeister K, Prusa AR, Kohlhauser C (2003) Evaluation of a netilmicin-loading dose in very low birth-weight infants. Biol Neonate 83:25\u201329","journal-title":"Biol Neonate"},{"key":"599_CR38","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s00228-006-0153-8","volume":"62","author":"J Rengelshausen","year":"2006","unstructured":"Rengelshausen J, Beeden A, Tsamouranis K, Mokus G, Walter-sack I, Haefeli WE, Linderkamp O (2006) Pharmacokinetics of a netilmicin loading dose on the first postnatal day in preterm neonates with very low gestational age. Eur J Clin Pharmacol 62:773\u2013777","journal-title":"Eur J Clin Pharmacol"},{"key":"599_CR39","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/S0009-9236(97)90117-X","volume":"62","author":"M Hoog de","year":"1997","unstructured":"de Hoog M, Schoemaker RC, Mouton JW, van den Anker JN (1997) Tobramycin population pharmacokinetics in neonates. Clin Pharmacol Ther 62:392\u2013399","journal-title":"Clin Pharmacol Ther"},{"key":"599_CR40","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1067\/mcp.2002.123595","volume":"71","author":"M Hoog de","year":"2002","unstructured":"de Hoog M, Mouton JW, Schormaker RC, Verduin CM, van den Anker JN (2002) Extended-interval dosing of tobramycin in neonates: implications for therapeutic drug monitoring. Clin Pharmacol Ther 71:349\u201358","journal-title":"Clin Pharmacol Ther"},{"key":"599_CR41","first-page":"1419","volume":"143","author":"PS Keyes","year":"1989","unstructured":"Keyes PS, Johnson CK, Rawlins TD (1989) Predictors of trough serum gentamicin concentrations in neonates. Am J Dis Child 143:1419\u20131423","journal-title":"Am J Dis Child"},{"key":"599_CR42","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1159\/000457090","volume":"9","author":"MC Nahata","year":"1986","unstructured":"Nahata MC, Durrel DE, Miller MA (1986) Tobramycin pharmacokinetics in premature identical twins during newborn period. Dev Pharmacol Ther 9:178\u2013182","journal-title":"Dev Pharmacol Ther"},{"key":"599_CR43","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1136\/adc.67.1_Spec_No.57","volume":"67","author":"H Skopnik","year":"1992","unstructured":"Skopnik H, Wallraf R, Nies A, Troster K, Heimann G (1992) Pharmacokinetics and antibacterial activity of daily gentamicin. Arch Dis Child 67:57\u201371","journal-title":"Arch Dis Child"},{"key":"599_CR44","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/00007691-200206000-00006","volume":"24","author":"M Hoog de","year":"2002","unstructured":"de Hoog M, Schoemaker RC, van den Anker JN, Vinks AA (2002b) NONMEM and NPEM2 population modeling: a comparison using tobramycin data in neonates. Ther Drug Monit 24:359\u2013365","journal-title":"Ther Drug Monit"},{"key":"599_CR45","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/j.1365-2125.1986.tb05198.x","volume":"21","author":"MC Nahata","year":"1986","unstructured":"Nahata MC, Powel DA, Durrel DE, Miller MA (1986) Tobramycin pharmacokinetics in very low birth weight infants. Br J Clin Pharmacol 21:325\u2013327","journal-title":"Br J Clin Pharmacol"},{"key":"599_CR46","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1159\/000457566","volume":"30","author":"JP Langhendries","year":"1993","unstructured":"Langhendries JP, Battisti O, Bertrand JM, Francois A, Darmiont J, Ibrahim S, Tulkens PM, Bernard A, Buchet JP, Scalais E (1993) Once-a-day administration of amikacin in neonates: assessment of nephrotoxicity and ototoxicity. Dev Pharmacol Ther 30:220\u2013230","journal-title":"Dev Pharmacol Ther"},{"key":"599_CR47","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1128\/AAC.46.5.1381-1387.2002","volume":"46","author":"JM Tr\u00e9luyer","year":"2002","unstructured":"Tr\u00e9luyer JM, Merl\u00e9 Y, Tonnelier S, Rey E, Pons G (2002) Nonparametric population pharmacokinetic analysis of amikacin in neonates, infants and children. Antimicrob Agents Chemother 46:1381\u20131387","journal-title":"Antimicrob Agents Chemother"},{"key":"599_CR48","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1365-2125.2005.02530.x","volume":"61","author":"K Allegaert","year":"2005","unstructured":"Allegaert K, Anderson BJ, Cossey V, Holford NHG (2005) Limited predictability of amikacin clearance in extreme premature neonates at birth. Br J Clin Pharmacol 61:39\u201348","journal-title":"Br J Clin Pharmacol"},{"key":"599_CR49","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1203\/00006450-198210000-00002","volume":"16","author":"BM Assael","year":"1982","unstructured":"Assael BM, Parini R, Rusconi F, Cavanna G (1982) Influence of intrauterine maturation on the pharmacokinetics of amikacin in the neonatal period. Pediat Res 16:810\u2013815","journal-title":"Pediat Res"},{"key":"599_CR50","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/00007691-199206000-00001","volume":"14","author":"M Izquierdo","year":"1992","unstructured":"Izquierdo M, Lanao JM, Cervero L, Jimenez NV, Dominguez-Gil A (1992) Population pharmacokinetics of gentamicin in premature infants. Ther Drug Monitor 14:177\u2013183","journal-title":"Ther Drug Monitor"},{"key":"599_CR51","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s002280100355","volume":"57","author":"N Bleyzac","year":"2001","unstructured":"Bleyzac N, Varnier V, Labaune JM, Corvasier S, Maire P, Jelliffe RW, Putet G, Aulagner G (2001) Population pharmacokinetics of amikacin at birth and interindividual variability in renal maturation. Eur J Clin Pharmacol 57:499\u2013504","journal-title":"Eur J Clin Pharmacol"},{"key":"599_CR52","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000457558","volume":"20","author":"EM Padovani","year":"1993","unstructured":"Padovani EM, Pistolesi C, Fanos V, Messori A, Martini N (1993) Pharmacokinetics of amikacin in neonates. Dev Pharmacol Ther 20:167\u2013173","journal-title":"Dev Pharmacol Ther"},{"key":"599_CR53","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1159\/000457186","volume":"7","author":"C Kildoo","year":"1984","unstructured":"Kildoo C, Modanlou HD, Komatsu G, Harralson A (1984) Development pattern of gentamicin kinetics in very low birth weight sick infants. Dev Pharmacol Ther 7:345\u2013356","journal-title":"Dev Pharmacol Ther"},{"key":"599_CR54","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/BF00857868","volume":"5","author":"LP Brion","year":"1991","unstructured":"Brion LP, Fleishchman AR, Schwartz GJ (1991) Gentamicin interval in newborn infants as determined by renal function and postconceptional age. Pediatr Nephrol 5:675\u2013678","journal-title":"Pediatr Nephrol"},{"key":"599_CR55","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1128\/AAC.36.7.1499","volume":"36","author":"A Vigan\u00f2","year":"1992","unstructured":"Vigan\u00f2 A, Principi N, Brivio L, Tommasi P, Stasi P, Dalla Villa A (1992) Comparison of 5 milligrams of netilmicin per kilogram of body weight versus 2 milligrams per kilogram thrice daily for treatment of Gram-negative pyelonephritis in children. Antimicrob Agents Chemother 36:1499\u20131503","journal-title":"Antimicrob Agents Chemother"},{"issue":"Suppl 2","key":"599_CR56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1080\/1120009X.2007.11782443","volume":"19","author":"M Testa","year":"2007","unstructured":"Testa M, Fanos V, Martinelli V, Strognati M, Mussap P, Del Zompo M (2007) Therapeutic drug monitoring of gentamicin in neonatal intensive care unit: experience in 68 newborns. Chemother 19(Suppl 2):39\u201341","journal-title":"Chemother"},{"key":"599_CR57","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1592\/phco.23.5.585.32196","volume":"32","author":"R Cenzo Di","year":"2003","unstructured":"Di Cenzo R, Forrest A, Slish JC, Cole C, Guillet R (2003) A gentamicin pharmacokinetic population model and once-daily dosing algoritm for neonates. Pharmacotherapy 32:585\u2013591","journal-title":"Pharmacotherapy"},{"key":"599_CR58","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1093\/ajhp\/55.12.1306","volume":"55","author":"JE Murphy","year":"1998","unstructured":"Murphy JE, Austin ML, Frye RF (1998) Evaluation of gentamicin pharmacokinetics and dosing protocols in 195 neonates. Am J Health-Syst Pharm 55:2280\u20132288","journal-title":"Am J Health-Syst Pharm"},{"key":"599_CR59","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/00007691-199910000-00004","volume":"21","author":"ML Vervelde","year":"1999","unstructured":"Vervelde ML, Rademarker CMA, Krediet TG, Fleer A, Asten PV, van Dijk A (1999) Population pharmacokinetics of gentamicin in preterm neonates: evaluation of a once-daily dosage regimen. Ther Drug Monitor 21:541\u2013519","journal-title":"Ther Drug Monitor"},{"key":"599_CR60","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1067\/mcp.2000.106695","volume":"67","author":"JM Tr\u00e9luyer","year":"2000","unstructured":"Tr\u00e9luyer JM, Merl\u00e9 Y, Semlali A, Pons G (2000) Population pharmacokinetic analysis of netilmicin in neonates and infants with use of a nonparametric method. Clin Pharmacol Ther 67:600\u2013609","journal-title":"Clin Pharmacol Ther"},{"key":"599_CR61","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF01640938","volume":"7","author":"H Yoshioka","year":"1979","unstructured":"Yoshioka H, Takimoto M, Fujita K, Maruyama S (1979) Pharmacokinetics of tobramycin in the newborn. Infection 7:180\u2013182","journal-title":"Infection"},{"key":"599_CR62","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1002\/cpt197620159","volume":"20","author":"H Sardemann","year":"1976","unstructured":"Sardemann H, Colding H, Hendel J, Kampmann JP, Hvidberg EF, Vejisgaard R (1976) Kinetics and dose calculations of amikacin in the newborn. Clin Pharmacol Ther 20:59\u201366","journal-title":"Clin Pharmacol Ther"},{"key":"599_CR63","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1128\/AAC.34.2.265","volume":"34","author":"CF Kenyon","year":"1990","unstructured":"Kenyon CF, Knoppert DC, Lee SK, Wandenberghe HM, Chance GW (1990) Amikacin pharmacokinetics and suggested dosage modifications for preterm infant. Antimicrob Agents Chemother 34:265\u2013268","journal-title":"Antimicrob Agents Chemother"},{"key":"599_CR64","first-page":"954","volume":"21","author":"J Wang","year":"2000","unstructured":"Wang J, Liang W-Q, Wu J-J, Pan C-M (2000) Population pharmacokinetics analysis of amikacin and validation on neonates using Monte Carlo method. Acta Pharmacol Sin 21:954\u2013960","journal-title":"Acta Pharmacol Sin"},{"key":"599_CR65","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1159\/000079618","volume":"86","author":"K Allegaert","year":"2004","unstructured":"Allegaert K, Cossey V, Langhendries JP, Nauleers G, Vanhole C, Devlieger H, Van Overmeire A (2004) Effects of co-administration of ibuprofen-lysine on the pharmacokinetics of amikacin in preterm infants during the first days of life. Biol Neonate 86:207\u2013211","journal-title":"Biol Neonate"}],"container-title":["European Journal of Clinical Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-008-0599-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00228-008-0599-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00228-008-0599-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,28]],"date-time":"2021-09-28T10:50:23Z","timestamp":1632826223000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00228-008-0599-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12,23]]},"references-count":65,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,4]]}},"alternative-id":["599"],"URL":"https:\/\/doi.org\/10.1007\/s00228-008-0599-y","relation":{},"ISSN":["0031-6970","1432-1041"],"issn-type":[{"value":"0031-6970","type":"print"},{"value":"1432-1041","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,12,23]]}}}